Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 4
1988 2
1989 5
1990 2
1991 10
1992 3
1993 4
1994 6
1995 3
1996 5
1998 4
2000 1
2001 5
2003 1
2008 2
2009 1
2010 1
2011 2
2012 1
2014 3
2015 1
2016 1
2017 1
2018 5
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.
Meliani A, Boisgerault F, Hardet R, Marmier S, Collaud F, Ronzitti G, Leborgne C, Costa Verdera H, Simon Sola M, Charles S, Vignaud A, van Wittenberghe L, Manni G, Christophe O, Fallarino F, Roy C, Michaud A, Ilyinskii P, Kishimoto TK, Mingozzi F. Meliani A, et al. Among authors: kishimoto tk. Nat Commun. 2018 Oct 5;9(1):4098. doi: 10.1038/s41467-018-06621-3. Nat Commun. 2018. PMID: 30291246 Free PMC article.
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Maldonado RA, LaMothe RA, Ferrari JD, Zhang AH, Rossi RJ, Kolte PN, Griset AP, O'Neil C, Altreuter DH, Browning E, Johnston L, Farokhzad OC, Langer R, Scott DW, von Andrian UH, Kishimoto TK. Maldonado RA, et al. Among authors: kishimoto tk. Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E156-65. doi: 10.1073/pnas.1408686111. Epub 2014 Dec 29. Proc Natl Acad Sci U S A. 2015. PMID: 25548186 Free PMC article.
The leukocyte integrins.
Kishimoto TK, Larson RS, Corbi AL, Dustin ML, Staunton DE, Springer TA. Kishimoto TK, et al. Adv Immunol. 1989;46:149-82. doi: 10.1016/s0065-2776(08)60653-7. Adv Immunol. 1989. PMID: 2551146 Review. No abstract available.
Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector.
De Sabbata G, Boisgerault F, Guarnaccia C, Iaconcig A, Bortolussi G, Collaud F, Ronzitti G, Sola MS, Vidal P, Rouillon J, Charles S, Nicastro E, D'Antiga L, Ilyinskii P, Mingozzi F, Kishimoto TK, Muro AF. De Sabbata G, et al. Among authors: kishimoto tk. Mol Ther Methods Clin Dev. 2020 Nov 17;20:169-180. doi: 10.1016/j.omtm.2020.11.005. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2020. PMID: 33473356 Free PMC article.
Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.
LaMothe RA, Kolte PN, Vo T, Ferrari JD, Gelsinger TC, Wong J, Chan VT, Ahmed S, Srinivasan A, Deitemeyer P, Maldonado RA, Kishimoto TK. LaMothe RA, et al. Among authors: kishimoto tk. Front Immunol. 2018 Mar 2;9:281. doi: 10.3389/fimmu.2018.00281. eCollection 2018. Front Immunol. 2018. PMID: 29552007 Free PMC article.
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles.
Kishimoto TK, Ferrari JD, LaMothe RA, Kolte PN, Griset AP, O'Neil C, Chan V, Browning E, Chalishazar A, Kuhlman W, Fu FN, Viseux N, Altreuter DH, Johnston L, Maldonado RA. Kishimoto TK, et al. Nat Nanotechnol. 2016 Oct;11(10):890-899. doi: 10.1038/nnano.2016.135. Epub 2016 Aug 1. Nat Nanotechnol. 2016. PMID: 27479756
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page